These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 21887711)

  • 41. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
    Lee JT; Wheeler TC; Li L; Chin LS
    Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Staged pathology in Parkinson's disease.
    Alafuzoff I; Parkkinen L
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S57-61. PubMed ID: 24262190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parkinson's disease.
    Mhyre TR; Boyd JT; Hamill RW; Maguire-Zeiss KA
    Subcell Biochem; 2012; 65():389-455. PubMed ID: 23225012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies.
    Hardenberg MC; Sinnige T; Casford S; Dada ST; Poudel C; Robinson EA; Fuxreiter M; Kaminksi CF; Kaminski Schierle GS; Nollen EAA; Dobson CM; Vendruscolo M
    J Mol Cell Biol; 2021 Aug; 13(4):282-294. PubMed ID: 33386842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's disease.
    Matsui H; Ito S; Matsui H; Ito J; Gabdulkhaev R; Hirose M; Yamanaka T; Koyama A; Kato T; Tanaka M; Uemura N; Matsui N; Hirokawa S; Yoshihama M; Shimozawa A; Kubo SI; Iwasaki K; Hasegawa M; Takahashi R; Hirai K; Kakita A; Onodera O
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2214652120. PubMed ID: 37252975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease.
    Kardani J; Sethi R; Roy I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1454-1463. PubMed ID: 28167231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of mutant GBA1 on accumulation and aggregation of α-synuclein.
    Maor G; Rapaport D; Horowitz M
    Hum Mol Genet; 2019 Jun; 28(11):1768-1781. PubMed ID: 30615125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
    Engelender S
    Autophagy; 2008 Apr; 4(3):372-4. PubMed ID: 18216494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation.
    Pimentel MM; Rodrigues FC; Leite MA; Campos Júnior M; Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; Della Coletta MV; Vasconcellos LF; Abreu GM; Dos Santos JM; Santos-Rebouças CB
    Parkinsonism Relat Disord; 2015 Jun; 21(6):586-9. PubMed ID: 25817515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.
    Dehay B; Bourdenx M; Gorry P; Przedborski S; Vila M; Hunot S; Singleton A; Olanow CW; Merchant KM; Bezard E; Petsko GA; Meissner WG
    Lancet Neurol; 2015 Aug; 14(8):855-866. PubMed ID: 26050140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease.
    Béraud D; Maguire-Zeiss KA
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1(0 1):S17-20. PubMed ID: 22166424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease.
    Li HY; Liu DS; Zhang YB; Rong H; Zhang XJ
    Biophys Chem; 2023 Dec; 303():107122. PubMed ID: 37839353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-synuclein dysfunction in Lewy body diseases.
    Tofaris GK; Spillantini MG
    Mov Disord; 2005 Aug; 20 Suppl 12():S37-44. PubMed ID: 16092089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structured regions of α-synuclein fibrils include the early-onset Parkinson's disease mutation sites.
    Comellas G; Lemkau LR; Nieuwkoop AJ; Kloepper KD; Ladror DT; Ebisu R; Woods WS; Lipton AS; George JM; Rienstra CM
    J Mol Biol; 2011 Aug; 411(4):881-95. PubMed ID: 21718702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.